Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release May 21 2024

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-21-2024-5

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 21, 2024, titled "Glenmark and BeiGene Enter into an Agreement for Marketing and Distribution of Tislelizumab and Zanubrutinib in India".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

In the deck

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases